# Frontage Laboratories

Frontage Laboratories is an Asset Manager based in Exton, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Exton, United States
- **Region:** North America
- **Address:** Exton, PA, United States
- **Assets under management:** Undisclosed
- **Website:** frontagelab.com
- **LinkedIn:** https://www.linkedin.com/company/frontage-laboratories-inc

## Regulatory record

- **Reports private funds:** No

## About

Frontage Laboratories is a global pharmaceutical development organization (PDO) advancing drug discovery and development through integrated laboratory and clinical services.

## Sectors

- Pharmaceutical Services
- Biotechnology
- AgriTech & FoodTech

## Offices

- Canada
- China
- Europe

## Questions

### How does Frontage integrate discovery and development services that are usually split among separate vendors?

Frontage operates unified global quality systems that apply the same SOPs to every site. A sponsor's lead candidate can move from medicinal chemistry through DMPK, safety toxicology, and Phase I clinical-trial-material manufacturing without leaving Frontage's quality envelope. The firm credits this architecture with compressing timelines and lowering the data-reconciliation risk that arises when multiple CROs hand off work at each gate.

### What is Frontage's geographic split, and how does it affect client programs?

The firm maintains 25 sites: 12 in North America, 12 in China, and one in Europe. The dual US-China footprint lets sponsors run parallel discovery campaigns or GLP toxicology studies in both regions under the same quality framework. Frontage explicitly markets this as a way to reduce costs and accelerate IND filings by matching a program's stage to the appropriate geography without changing vendors.

### Does Frontage operate strictly as a CRO, or does it manufacture clinical-trial materials as well?

Frontage functions as both a CRO and a CDMO. Its CMC division handles formulation development, analytical services, and clinical-trial-material manufacturing for NCE, 505(b)(2), and ANDA products through Phase III. This means a sponsor can use Frontage for everything up to and including the drug product used in first-in-human studies, rather than contracting a separate CDMO after preclinical work wraps.

### Which sector outside human pharma does Frontage serve, and how is that unit structured?

Frontage runs a dedicated agrochemical division that provides biological, chemical, and regulatory support within a GLP-compliant facility. The firm frames this as a natural extension of its analytical and toxicology capabilities, applying the same quality infrastructure to crop-protection products that it uses for small-molecule drugs.

## Related profiles

- [TransMedics](https://altss.com/profile/transmedics)
- [TaylorMade Golf](https://altss.com/profile/taylor-made-golf-company)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/frontage-holdings-corporation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology